These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1437 related items for PubMed ID: 31986086

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Pathophysiology and Therapeutic Approaches to Cardiac Amyloidosis.
    Griffin JM, Rosenblum H, Maurer MS.
    Circ Res; 2021 May 14; 128(10):1554-1575. PubMed ID: 33983835
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Transthyretin cardiac amyloidosis: A treatable form of heart failure with a preserved ejection fraction.
    Griffin JM, Maurer MS.
    Trends Cardiovasc Med; 2021 Jan 14; 31(1):59-66. PubMed ID: 31889610
    [Abstract] [Full Text] [Related]

  • 5. A Review of Novel Agents and Clinical Considerations in Patients With ATTR Cardiac Amyloidosis.
    Benbrahim M, Norman K, Sanchorawala V, Siddiqi OK, Hughes D.
    J Cardiovasc Pharmacol; 2021 May 01; 77(5):544-548. PubMed ID: 33657048
    [Abstract] [Full Text] [Related]

  • 6. Natural history and therapy of TTR-cardiac amyloidosis: emerging disease-modifying therapies from organ transplantation to stabilizer and silencer drugs.
    Castaño A, Drachman BM, Judge D, Maurer MS.
    Heart Fail Rev; 2015 Mar 01; 20(2):163-78. PubMed ID: 25408161
    [Abstract] [Full Text] [Related]

  • 7. Cardiac amyloidosis-interdisciplinary approach to diagnosis and therapy.
    Hänselmann A, Berliner D, Bauersachs J, Bavendiek U.
    Herz; 2022 Aug 01; 47(4):324-331. PubMed ID: 35674775
    [Abstract] [Full Text] [Related]

  • 8. Advances in the diagnosis and treatment of transthyretin amyloidosis with cardiac involvement.
    Rigopoulos AG, Ali M, Abate E, Torky AR, Matiakis M, Mammadov M, Melnyk H, Vogt A, de Vecchis R, Bigalke B, Wohlgemuth W, Mavrogeni S, Noutsias M.
    Heart Fail Rev; 2019 Jul 01; 24(4):521-533. PubMed ID: 30790171
    [Abstract] [Full Text] [Related]

  • 9. Misconceptions and Facts About Cardiac Amyloidosis.
    Nguyen FD, Rodriguez M, Krittanawong C, Witteles R, Lenihan DJ.
    Am J Cardiol; 2021 Dec 01; 160():99-105. PubMed ID: 34610875
    [Abstract] [Full Text] [Related]

  • 10. Transthyretin Cardiac Amyloidosis: An Evolution in Diagnosis and Management of an "Old" Disease.
    Smiley DA, Rodriguez CM, Maurer MS.
    Cardiol Clin; 2022 Nov 01; 40(4):541-558. PubMed ID: 36210137
    [Abstract] [Full Text] [Related]

  • 11. Subtype-Specific Interactions and Prognosis in Cardiac Amyloidosis.
    Sperry BW, Vranian MN, Hachamovitch R, Joshi H, Ikram A, Phelan D, Hanna M.
    J Am Heart Assoc; 2016 Mar 24; 5(3):e002877. PubMed ID: 27013539
    [Abstract] [Full Text] [Related]

  • 12. Cardiac amyloidosis: updates in diagnosis and management.
    Mohty D, Damy T, Cosnay P, Echahidi N, Casset-Senon D, Virot P, Jaccard A.
    Arch Cardiovasc Dis; 2013 Oct 24; 106(10):528-40. PubMed ID: 24070600
    [Abstract] [Full Text] [Related]

  • 13. Cardiac Amyloidosis Treatment.
    Stern LK, Patel J.
    Methodist Debakey Cardiovasc J; 2022 Oct 24; 18(2):59-72. PubMed ID: 35414852
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Prevalence, Characteristics, and Impact on Prognosis of Aortic Stenosis in Patients With Cardiac Amyloidosis.
    Annabi MS, Carter-Storch R, Zaroui A, Galat A, Oghina S, Kharoubi M, Bezard M, Derumeaux G, Fanen P, Lemonnier F, Poullot E, Itti E, Gallet R, Teiger E, Pibarot P, Damy T, Clavel MA.
    J Am Heart Assoc; 2024 Jul 02; 13(13):e034723. PubMed ID: 38904242
    [Abstract] [Full Text] [Related]

  • 17. Diagnosis and Treatment of Transthyretin Cardiac Amyloidosis. Progress and Hope.
    González-López E, López-Sainz Á, Garcia-Pavia P.
    Rev Esp Cardiol (Engl Ed); 2017 Nov 02; 70(11):991-1004. PubMed ID: 28870641
    [Abstract] [Full Text] [Related]

  • 18. How to Identify Transthyretin Cardiac Amyloidosis at an Early Stage.
    Izumiya Y, Hayashi H, Ishikawa H, Shibata A, Yoshiyama M.
    Intern Med; 2021 Jan 01; 60(1):1-7. PubMed ID: 32713926
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 72.